Historic Cancer Center Signs on to Participate in CancerLinQ Platform

More than 105 have signed up to participate and 60 are currently using CancerLinQ
For immediate release
March 4, 2020


Kate Crawford

ALEXANDRIA, Va. – Roswell Park Comprehensive Cancer Center of Buffalo, N.Y., has just signed an agreement to use the CancerLinQ® platform. The first cancer center in the U.S., established in 1898, Roswell Park is one of many practices to join the CancerLinQ® family in recent months.

Roswell Park was recognized in 1972 as one of the first three National Cancer Institute-Designated Comprehensive Cancer Centers. Today, it is one of 28 National Comprehensive Cancer Network (NCCN) members, all leading academic cancer centers in the country.

“We at Roswell are excited to join CancerLinQ,” said Stephen Edge, MD, FACS, FASCO, Vice President of Healthcare Outcomes and Policy at Roswell Park. “We hope to use it to enhance our quality oversight, benchmark care, use with other data to better understand care delivery and quality, and support local and national research efforts.”

CancerLinQ currently has more than 100 subscribers. In addition to Roswell Park, many practices, including Baptist Healthcare System in Louisville, Ky., and Crystal Run Healthcare in Middletown, N.Y., have signed agreements to join the platform during the past six months.

Sixty practices have completed the onboarding process to establish a link between the CancerLinQ database and their electronic health record (EHR) system, and more than 1.5 million de-identified, real-world cancer patient records are now in the database. CancerLinQ is now helping these practices improve patient care through quality automation tools and dashboards and reports that provide actionable insights.

“The CancerLinQ database reflects cancer care in all its real-world variability, including practice settings, communities, and age of patients being treated,” said CancerLinQ CEO Cory Wiegert. “Practices who participate are able to access a platform that enables them to meet quality reporting requirements in a more seamless fashion and discover insights that can improve the care they provide.”

CancerLinQ® and CancerLinQ Discovery® are products of CancerLinQ LLC. For more information on how to participate, please visit CancerLinQ.org.

About ASCO: 

About the American Society of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.


About CancerLinQ LLC
CancerLinQ® and CancerLinQ Discovery® are projects of CancerLinQ LLC. CancerLinQ LLC is a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO) established for the development and operation of the CancerLinQ® initiative. CancerLinQ collects and analyzes real-world cancer care data from multiple healthcare IT systems in order improve the quality of care and health care operations. CancerLinQ Discovery® provides data and analytics to the oncology community that can generate practical knowledge to shape the future of cancer care. To learn more, visit www.cancerlinq.org.